Adolescents News and Research

RSS

Adolescents with higher levels of omega-3 fatty acids less likely to develop psychotic disorder

New research has found that adolescents with higher levels of an omega-3 fatty acid in their blood were less likely to develop psychotic disorder in early adulthood, suggesting that it may have a potential preventative effect of reducing the risk of psychosis.

1 Jun 2021

Researchers develop proof-of-concept treatment for blood disorders

Researchers at Children's Hospital of Philadelphia (CHOP) have developed a proof-of-concept treatment for blood disorders like sickle cell disease and beta-thalassemia that could raise hemoglobin levels by activating production of both fetal and adult hemoglobin.

1 Jun 2021

Supportive family environment can reduce effects of social deprivation among adopted children

An environment in which family members support one another and express their feelings can reduce the effects of social deprivation on cognitive ability and development among adopted children, suggests a small study by researchers at the National Institutes of Health.

29 May 2021

Ban on flavored vaping could have increased smoking habits in youth

When San Francisco voters overwhelmingly approved a ballot measure banning the sale of flavored tobacco products in 2018, public health advocates celebrated. After all, tobacco use poses a significant threat to public health and health equity, and flavors are particularly attractive to youth.

29 May 2021

Study exposes cognitive vulnerabilities to soft drink advertisements

What keeps consumers hooked on high sugar soft drink? Advertising, of course. But why are some consumers more adept at ignoring these cues than others?

28 May 2021

KHN’s ‘what the health?’: The return of the public option

The "public option" is back — both in Washington, D.C., and the states. President Joe Biden as a candidate supported the idea of a government-run or heavily regulated insurance plan that would compete with private insurance.

28 May 2021

Study shows more evidence that vaccines are safe for children, adults

A new study looking across a large body of research finds further evidence for the safety of vaccines that are Food and Drug Administration-approved and routinely recommended for children, adults and pregnant women.

27 May 2021

Vast majority of Black adolescents have experienced racism, shows study

A recent study finds that the vast majority of Black adolescents have experienced racism, that they experience anticipatory stress about experiencing racism again, and that their racial identity can influence that stress in a variety of ways.

26 May 2021

International Day of Action for Women’s Health: An Interview with UN Women

In commemoration of the International Day of Action for Women's Health, we interviewed Nazneen Damji, from UN Women, about women's health in 2021.

26 May 2021

Study shows how rare but serious post-COVID-19 complication develops in children, adolescents

A multidisciplinary team from MassGeneral Hospital for Children (MGHfC), Brigham and Women's Hospital and other institutions have identified the mechanism of how an extremely rare but serious post-COVID-19 complication develops in children and adolescents.

26 May 2021

Kennedy Krieger Institute researcher wins NIH award for movement learning study

The National Institutes of Health (NIH) recently awarded Amy Bastian, Ph.D., PT, chief science officer and director of the Motion Analysis Lab at Kennedy Krieger Institute, with an eight-year, $4.7 million National Institute of Neurological Disorders and Stroke (NINDS) Research Program Award (N35) to support a study examining movement learning mechanisms and how this process is affected by brain damage.

26 May 2021

Person infected with SARS-CoV-2 can transmit infection to three to five other people

What started as the preliminary analysis of routine laboratory data has since evolved into the largest-ever study of viral load levels in patients with SARS-CoV-2.

25 May 2021

China makes remarkable progress in reducing number of maternal and infant deaths

China has made remarkable gains in reducing the number of women who die during childbirth and boosting child survival rates over the past 70 years, according to new review.

25 May 2021

Study: Four-month regimen of anti-TB drugs works just as well as standard regimen

A new four-month regimen of anti-TB drugs that includes rifapentine and moxifloxacin works just as well as the standard six-month regimen, according to a study.

24 May 2021

Trial results show upadacitinib to be the most effective treatment for atopic dermatitis

The findings of a clinical trial by Trinity College Dublin researchers of treatment for atopic dermatitis have been published today in The Lancet journal (Friday, 21st May, 2021).

21 May 2021

Parents and young adults urged to get HPV vaccination back on track

Sanford Burnham Prebys has joined doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations to issue a joint statement urging the nation's physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.

21 May 2021

Swiss study suggests very low prevalence of long COVID in pediatric population

Researchers from Switzerland recently analyzed long COVID symptoms in children and adolescents with a 6-month follow-up based on their SARS-CoV-2 serology. A longitudinal cohort analysis, the Ciao Corona study investigated SARS-CoV-2 seroprevalence and case clustering among ~2500 children from 55 primary and secondary schools in Zurich, Switzerland.

20 May 2021

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.

20 May 2021

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.

20 May 2021

Triple-drug therapy can reduce asthma exacerbations, improve control without major adverse events

Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults with moderate-to-severe asthma.

20 May 2021

Adolescents News and Research

Adolescents with higher levels of omega-3 fatty acids less likely to develop psychotic disorder

Researchers develop proof-of-concept treatment for blood disorders

Supportive family environment can reduce effects of social deprivation among adopted children

Ban on flavored vaping could have increased smoking habits in youth

Study exposes cognitive vulnerabilities to soft drink advertisements

KHN’s ‘what the health?’: The return of the public option

Study shows more evidence that vaccines are safe for children, adults

Vast majority of Black adolescents have experienced racism, shows study

International Day of Action for Women’s Health: An Interview with UN Women

Study shows how rare but serious post-COVID-19 complication develops in children, adolescents

Kennedy Krieger Institute researcher wins NIH award for movement learning study

Person infected with SARS-CoV-2 can transmit infection to three to five other people

China makes remarkable progress in reducing number of maternal and infant deaths

Study: Four-month regimen of anti-TB drugs works just as well as standard regimen

Trial results show upadacitinib to be the most effective treatment for atopic dermatitis

Parents and young adults urged to get HPV vaccination back on track

Swiss study suggests very low prevalence of long COVID in pediatric population

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Triple-drug therapy can reduce asthma exacerbations, improve control without major adverse events

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News